Submitted by Anonymous (not verified) on 14 January 2026 - 14:40
Human medicines European public assessment report (EPAR): Yesafili, aflibercept, Date of authorisation: 15/09/2023, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Yesafili, aflibercept, Date of authorisation: 15/09/2023, Revision: 7, Status: Authorised